The Association Between Low Socioeconomic Status With High Physical Limitations and Low Illness Self‐Perception in Patients With Juvenile Idiopathic Arthritis: Results From the Childhood Arthritis Prospective Study

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 3, 2015-03 ,pp. : 382-389

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of Adalimumab as the First and Second Biologic Agent in Juvenile Idiopathic Arthritis: The German Biologics JIA Registry

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 9, 2014-09 ,pp. : 2580-2589

John Wiley & Sons Inc

Access to resources Recommend Favorite

Critical Appraisal of Studies Measuring Quality of Life in Juvenile Idiopathic Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 6, 2015-05 ,pp. : 880-884

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of Etanercept in Patients With the Enthesitis‐Related Arthritis Category of Juvenile Idiopathic Arthritis: Results From a Phase III Randomized, Double‐Blind Study

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 8, 2015-05 ,pp. : 2240-2249

John Wiley & Sons Inc

Access to resources Recommend Favorite

Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for New‐Onset Polyarticular Juvenile Idiopathic Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 66, Iss. 7, 2014-07 ,pp. : 1063-1072

John Wiley & Sons Inc

Access to resources Recommend Favorite